Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma.
Lue HW, Derrick DS, Rao S, Van Gaest A, Cheng L, Podolak J, Lawson S, Xue C, Garg D, White R 3rd, Ryan CW, Drake JM, Ritz A, Heiser LM, Thomas GV.
Lue HW, et al. Among authors: van gaest a.
Cell Rep Med. 2021 May 7;2(5):100267. doi: 10.1016/j.xcrm.2021.100267. eCollection 2021 May 18.
Cell Rep Med. 2021.
PMID: 34095877
Free PMC article.